Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026.
- Largest single sale: $157K (2,607 shares) of Xenon Pharmaceuticals Inc. on Mar 10, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | Chief Legal Officer | Nov 9, 2022 | Mar 13, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 13, 2026, Xenon Pharmaceuticals Inc.: sold 1,342 shares for $74K, under a disclosed plan. 1 filing: 1
- Mar 12, 2026, Xenon Pharmaceuticals Inc.: 3,750 shares vested. 1 filing: 1
- Mar 10, 2026, Xenon Pharmaceuticals Inc.: sold 2,607 shares for $157K, under a disclosed plan. 1 filing: 1
- Mar 9, 2026, Xenon Pharmaceuticals Inc.: 7,500 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.